🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/05/2025 | 315,77 | 320,91 | 311,62 | 320,37 | +1,50% | 2,94% | 481.500 |
| 28/05/2025 | 316,92 | 319,10 | 315,00 | 315,64 | +0,25% | 1,29% | 425.100 |
| 27/05/2025 | 309,34 | 315,87 | 307,76 | 314,84 | +2,34% | 2,62% | 494.100 |
| 23/05/2025 | 305,76 | 310,16 | 302,79 | 307,65 | -0,35% | 2,41% | 269.600 |
| 22/05/2025 | 308,25 | 310,74 | 306,16 | 308,72 | -0,31% | 1,49% | 326.000 |
| 21/05/2025 | 306,91 | 310,97 | 305,44 | 309,68 | +0,04% | 1,80% | 321.100 |
| 20/05/2025 | 305,87 | 311,99 | 304,24 | 309,57 | +1,40% | 2,53% | 372.700 |
| 19/05/2025 | 304,68 | 306,13 | 300,51 | 305,31 | -0,01% | 1,84% | 640.300 |
| 16/05/2025 | 303,03 | 305,74 | 300,46 | 305,35 | +0,47% | 1,74% | 518.000 |
| 15/05/2025 | 301,26 | 303,94 | 292,61 | 303,92 | +1,41% | 3,76% | 486.900 |
| 14/05/2025 | 307,10 | 307,62 | 298,69 | 299,68 | -2,72% | 2,91% | 546.700 |
| 13/05/2025 | 308,37 | 310,09 | 301,97 | 308,07 | -0,88% | 2,63% | 757.300 |
| 12/05/2025 | 304,25 | 312,49 | 303,95 | 310,80 | +3,11% | 2,81% | 367.300 |
| 09/05/2025 | 308,26 | 313,35 | 301,23 | 301,42 | -2,14% | 3,93% | 335.300 |
| 08/05/2025 | 304,00 | 311,22 | 299,37 | 308,00 | +0,35% | 3,90% | 530.700 |
| 07/05/2025 | 299,46 | 309,25 | 295,30 | 306,92 | +4,03% | 4,66% | 525.600 |
| 06/05/2025 | 295,71 | 298,48 | 290,02 | 295,02 | -1,23% | 2,86% | 386.600 |
| 05/05/2025 | 294,52 | 299,45 | 292,02 | 298,70 | +1,39% | 2,52% | 295.700 |
| 02/05/2025 | 298,39 | 300,45 | 291,22 | 294,60 | +0,26% | 3,09% | 583.700 |
| 01/05/2025 | 304,79 | 304,79 | 292,52 | 293,85 | -3,05% | 4,03% | 427.100 |
| 30/04/2025 | 317,10 | 319,40 | 293,03 | 303,09 | +0,77% | 8,32% | 784.900 |
| 29/04/2025 | 294,59 | 301,52 | 291,41 | 300,76 | +1,25% | 3,43% | 574.900 |
| 28/04/2025 | 294,55 | 298,68 | 293,71 | 297,04 | +1,94% | 1,69% | 410.300 |
| 25/04/2025 | 290,31 | 293,74 | 286,93 | 291,38 | -1,70% | 2,35% | 311.500 |
| 24/04/2025 | 294,71 | 297,86 | 292,35 | 296,42 | +1,01% | 1,87% | 201.800 |
| 23/04/2025 | 295,62 | 298,30 | 291,68 | 293,46 | +0,22% | 2,24% | 225.300 |
| 22/04/2025 | 288,64 | 293,55 | 286,34 | 292,82 | +3,01% | 2,50% | 366.000 |
| 21/04/2025 | 285,57 | 291,11 | 281,41 | 284,25 | -0,17% | 3,40% | 338.600 |
| 17/04/2025 | 284,67 | 287,45 | 279,95 | 284,73 | -0,16% | 2,63% | 302.900 |
| 16/04/2025 | 285,98 | 288,54 | 281,51 | 285,19 | +0,13% | 2,46% | 332.800 |